ICON Public Limited (NASDAQ:ICLR – Free Report) – Investment analysts at Leerink Partnrs decreased their FY2024 earnings per share estimates for shares of ICON Public in a research note issued to investors on Wednesday, October 23rd. Leerink Partnrs analyst M. Cherny now anticipates that the medical research company will earn $14.50 per share for the year, down from their previous estimate of $14.55. Leerink Partnrs has a “Strong-Buy” rating on the stock. The consensus estimate for ICON Public’s current full-year earnings is $14.53 per share. Leerink Partnrs also issued estimates for ICON Public’s FY2025 earnings at $16.27 EPS, FY2026 earnings at $18.15 EPS and FY2027 earnings at $20.17 EPS.
ICON Public (NASDAQ:ICLR – Get Free Report) last posted its earnings results on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.72 by ($0.37). The company had revenue of $2.03 billion during the quarter, compared to analyst estimates of $2.13 billion. ICON Public had a net margin of 8.57% and a return on equity of 12.06%. ICON Public’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $3.10 EPS.
Get Our Latest Stock Analysis on ICLR
ICON Public Stock Down 0.6 %
Shares of NASDAQ:ICLR opened at $220.47 on Friday. The company has a 50 day moving average of $297.75 and a two-hundred day moving average of $310.20. ICON Public has a 52-week low of $220.01 and a 52-week high of $347.72. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $18.19 billion, a price-to-earnings ratio of 25.70, a price-to-earnings-growth ratio of 1.35 and a beta of 1.22.
Institutional Investors Weigh In On ICON Public
Institutional investors and hedge funds have recently made changes to their positions in the company. Arkadios Wealth Advisors bought a new stake in shares of ICON Public during the 1st quarter valued at about $247,000. Whittier Trust Co. boosted its stake in ICON Public by 21.9% in the first quarter. Whittier Trust Co. now owns 3,295 shares of the medical research company’s stock valued at $1,107,000 after acquiring an additional 593 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its stake in ICON Public by 410.8% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 189 shares of the medical research company’s stock valued at $63,000 after acquiring an additional 152 shares during the period. First National Bank of Hutchinson raised its position in shares of ICON Public by 5.7% during the 1st quarter. First National Bank of Hutchinson now owns 1,135 shares of the medical research company’s stock worth $381,000 after purchasing an additional 61 shares during the period. Finally, Motco raised its position in shares of ICON Public by 1.5% during the 1st quarter. Motco now owns 3,882 shares of the medical research company’s stock worth $1,304,000 after purchasing an additional 59 shares during the period. 95.61% of the stock is owned by institutional investors and hedge funds.
About ICON Public
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Featured Articles
- Five stocks we like better than ICON Public
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Roth IRA Calculator: Calculate Your Potential Returns
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.